Proton-pump inhibitors

Proton-pump inhibitors

Proton-pump inhibitors (PPIs) are a class of drugs that profoundly suppress gastric acid secretion, and thus have become the treatment of choice for gastro-oesophageal reflux disease and peptic ulcer disease. PPIs are considered safe and effective. It is essential that clinicians understand the appr...

Full description

Bibliographic Details
Main Author:	Vasudevan G. Naidoo
Format:	Article
Language:	English
Published:	AOSIS 2015-05-01
Series:	South African Family Practice
Subjects:	proton-pump inhibitors ppis gastro-oeseophageal reflux disease gord pud
Online Access:	https://safpj.co.za/index.php/safpj/article/view/4288

Similar Items

Gastro-oesophageal reflux: an overview of the pharmacotherapeutic treatment options
by: L Malan, et al.
Published: (2017-07-01)

Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options
by: Gustav Schellack, et al.
Published: (2016-03-01)

Influence of generics in prescribing dynamics of proton pump inhibitors in general practice
by: Simona Cammarota, et al.
Published: (2009-03-01)

In-hospital gastric protection with proton pump inhibitors: adverse effects beyond (over)utilization?
by: Paolo Montanari
Published: (2013-04-01)

Gastric pain
by: Natalie Schellack, et al.
Published: (2015-09-01)

Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis
by: Salman Hussain, et al.
Published: (2022-08-01)

Depression Events Associated with Proton-Pump Inhibitors in Postmarketing Drug Surveillance Data
by: Tigran Makunts, et al.
Published: (2023-08-01)

Chronic Asthma and Gastro-Esophageal Reﬂux Disease: The Treatment Plans
by: Leila Ghofraniha, et al.
Published: (2015-09-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
by: Byungkyu Ahn, et al.
Published: (2016-07-01)

Heartburn, gastro-oesophageal reflux disease and non-erosive reflux disease
by: Haley Smith
Published: (2016-11-01)

ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
by: N. E. Shabanova, et al.
Published: (2018-12-01)

Differentiated approach to the choice of PPI in a patient with GERD in the practice of an outpatient (with a clinical case)
by: I. G. Pakhomova, et al.
Published: (2021-01-01)

Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
by: Reidar Fossmark, et al.
Published: (2023-09-01)

Effects of a Proton-Pump Inhibitor on Postnasal Drip Symptoms in Patients With Laryngopharyngeal Reflux
by: Jun Yong Lee, et al.
Published: (2023-11-01)

Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study
by: Abukhalil AD, et al.
Published: (2023-01-01)

Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors
by: Leonid Borisovich Lazebnik, et al.
Published: (2012-02-01)

Gastro-oesophageal reflux: a mixed methods study of infants admitted to hospital in the first 12 months following birth in NSW (2000–2011)
by: Hannah Grace Dahlen, et al.
Published: (2018-02-01)

Prescribing pattern of proton pump inhibitors in Qatar rehabilitation institute: A retrospective study
by: Lama Madi, et al.
Published: (2019-01-01)

Eosinophilic Esophagitis on and off Proton Pump Inhibitor
by: Vincent Zimmer, et al.
Published: (2023-03-01)

Proton pumps inhibitors in gastroesophageal reflux disease: what is the best regimen? A based evidence review
by: Rui JF Silva, et al.
Published: (2021-07-01)

Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
by: Niels Westergaard, et al.
Published: (2021-02-01)

Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor
by: A. López-Colombo, et al.
Published: (2017-04-01)

The Effect of Esomeprazole 40 mg Single Therapy in Patients with Non-Erosive Reflux Disease Who Are Resistant to Standard-Dose Proton Pump Inhibitor Therapy: An Open-Label Multicenter Study
by: Jae Kyu Sung, et al.
Published: (2016-12-01)

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
by: Mermelstein J, et al.
Published: (2016-07-01)

The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis
by: Carolina Gutiérrez-Junquera, et al.
Published: (2018-05-01)

Efficacy of proton pump inhibitors combined with intensive diet intervention in treatment of laryngopharyngeal reflux disease
by: WANG Min, et al.
Published: (2019-11-01)

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
by: Sirinawasatien A, et al.
Published: (2019-07-01)

Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
by: Mousalreza Hosseini, et al.
Published: (2017-06-01)

Trial of transcutaneous electrical acupoint stimulation in laryngopharyngeal reflux disease: study protocol for a randomized controlled trial
by: Hailong Shen, et al.
Published: (2022-04-01)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01)

Inadequate response to proton pump inhibitor therapy: Causes and patient management tactics
by: Iu V Evsiutina, et al.
Published: (2015-02-01)

The Prevalence and Clinical Features of Non-responsive Gastroesophageal Reflux Disease to Practical Proton Pump Inhibitor Dose in Korea: A Multicenter Study
by: Hong Jun Park, et al.
Published: (2016-07-01)

Head of bed elevation to relieve gastroesophageal reflux symptoms: a systematic review
by: Loai Albarqouni, et al.
Published: (2021-01-01)

Effect of Proton Pump Inhibitors on Reflux Symptom Index (RSI) and Reflux Finding Score (RFS) in Patients with Laryngopharyngeal Reflux: A Systematic Review and Meta-Analysis
by: Patricia Ann Soriano, et al.
Published: (2022-06-01)

The strategy for choosing a new-generation proton pump inhibitor dexlansoprazole in the treatment of gastroesophageal reflux disease
by: N. V. Topchiy, et al.
Published: (2018-04-01)

Proton Pump Inhibitors Enhance the Antitumor Effect of Chemotherapy for Esophageal Squamous Cell Carcinoma
by: Shinya Matsumura, et al.
Published: (2022-05-01)

Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial
by: Jae Ho Cho, et al.
Published: (2020-08-01)

Proton pump inhibitors as treatment of laryngeal disorders among patients with gastroesophageal reflux disease: a single-arm (pre and post) quasi-experimental study
by: Mahmoud Ali Ragaee, et al.
Published: (2023-01-01)

The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors
by: AlShammari M, et al.
Published: (2020-03-01)